Quell Therapeutics Ltd (“Quell”), a world leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, announces that management will ...
In addition to developing microservices, Shanbhag's work includes designing high-performance, cloud-native systems that address the pressing demands of large-scale data handling in AI applications.